Fritextsökning
Innehållstyper
-
Study: Semaglutide tablet produces weight loss
The pharmaceutical semaglutide is effective for weight loss even when given in tablet form, according to a phase 3 study.
-
ZEISS Insights: Measurement of bone plates and screws
Get free access to technical paper.
-
Uncertainty about the government’s life science work
The government’s national coordinator for life science, Jenni Nordborg, left her position almost four months ago. No one has yet succeeded her, and now question...
-
Looking for greater Nordic cooperation – “We have Norway and Finland in our sights”
How can Medicon Valley Alliance bring the big pharmaceutical companies back to the organisation? Life Science Sweden discussed this topic and others with the cl...
-
Anna Törner: ”Orphan Designation – the "petite robe noire" of drug development”
It is easy to cling to various regulatory incentives, like orphan designation, and other expedited pathways, without understanding what they truly mean or wheth...
-
Samuel Lagercrantz: The government’s performance in healthcare and life sciences so far
Since the change of government in Sweden, developments in the healthcare sector have shown promising signs, but the outlook in life sciences is less promising, ...
-
Swedish and Ukrainian Medical Product Agencies sign an agreement
The Directors-General of the Swedish and Ukrainian Medical Products Agencies have signed a cooperation agreement.
-
Lundaforskare tilldelas pris från Novo Nordisk Foundation
Hindrik Mulder, professor vid Lunds universitet, får Novo Nordisk Foundation Lecture Prize för sin forskning på diabetes.
-
The Swedish innovation model: “There is a paradox”
It is often said that Sweden is strong when it comes to innovation, but how well are we turning that innovation into actual medicines?
-
Sweden is heavily criticised for not ordering Covid vaccine
Valneva and the EU Commission have entered into an agreement for 1.25 million doses of the company’s Covid vaccine, but Sweden has not placed an order.
-
Astra Zeneca’s Sweden CEO: “We have great faith in our portfolio”
It all started with a summer job as an operator at Astra’s chemical factory in Snäckviken, just outside Södertälje. More than three decades and countless differ...
-
Study: Popular diabetes treatment is not associated with thyroid cancer
Concerns raised about an association between GLP-1 analogues, used to treat diabetes and obesity, and an increased risk of thyroid cancer are not supported by a...
-
Inga spår av coronavirus när Londons tunnelbana undersöktes
En nyligen genomförd stickprovsundersökning i Londons tunnelbana visade inga spår av sars-cov-2.
-
ZEISS Quality Innovation Days
The leading digital event from April 15-19, 2024.
-
Ny ordförande för Atlas Antibodies
Åsa Riisberg, styrelseproffs och tidigare partner i EQT, tar över ordförandeklubban i Atlas Antibodies.
-
Lucy Robertshaw: Artificial intelligence – is this really going to transform a patient’s life?
In a column Lucy Robertshaw reflects on how AI and new regulations will affect healthcare, innovation and the lives of future patients.
-
Samuel Lagercrantz: A special kind of hellishness afflicts post-COVID patients
In addition to the disease itself those suffering from post-COVID have to deal with people who try to label them as hypochondriacs, writes Samuel Lagercrantz in an editorial.
-
Forskningscenter stoppas på grund av brister – ”Väldigt allvarligt”
Forskning som bedrivs utan tillstånd. Bristande kvalitetssäkring. Personuppgifter som hanteras felaktigt. Kritiken mot arbetet på Center for Bionics and Pain Re...
-
The Swedish Life Science Office: “We lost in both coordination and manpower”
Since the turn of the year, the Swedish government’s life science office has operated at a lower capacity. Life Science Sweden has spoken to Pontus Holm, Depart...
-
Antikroppar tog form med hjälp av artificiell intelligens
Språkmodeller, såsom Chat GPT, som bygger på artificiell intelligens kan användas till en rad olika saker. Nu har forskare, med en språkmodell tillverkad av ett...
-
Vinnova is going to establish a new innovation cluster
Vinnova, the Swedish Agency for Innovation Systems, has been commissioned by the government to establish a national innovation cluster for advanced medicines.
-
Automated opening and closing of sample vials
From technical requirements to a suitable solution
-
WHO utfärdar globalt nödläge efter mpox-utbrott
Världshälsoorganisationen WHO har återigen utlyst globalt nödläge på grund spridningen av mpox, tidigare kallat apkoppor.
-
CCRM Nordic rekryterar vetenskaplig chef
Anna Falk, professor vid Lunds universitet, blir Chief Scientific Officer på CCRM Nordic.
BREAKING